We all seem to be aware of the deadly effects of leukemia, especially in infants. The prevalence of the disease interferes with every sphere of our daily lives and activities. A combination of chemotherapy and stem cell transplant can find us relief though; they expose us to minor to severe side effects, including graft-versus-host-disease (GVHD), coupled with some complaints of toxicities as well. However, a recent research from Fred Hutchinson Cancer Research Center had confirmed that treatment with umbilical cord blood transplant offers a better survival outcome, without any need of a traditional donor match. So, all the leukemia patients need not to queue in the line for years to find a matched donor for their stem cell transplants.
Nor does the umbilical cord blood treatment offer better curative possibilities for patients with leukemia; it alleviates the chronic conditions associated with Myelodysplastic syndrome and other bone marrow disorders as well.
How Cord Blood Treatment Raises Hopes for Us Suffering from Leukemia
A study published in the New England Journal of Medicine by the Fred Hutchinson Cancer Research Center highlighted the benefits of cord blood treatments. And it is established that in patients with “minimal